Japanese Encephalitis

Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

Post-licensure Safety Study of IMOJEV® in Thailand

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Immunogenicity Study of the Japanese Encephalitis Vaccine IC51

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

Postmarketing Surveillance Study for IMOJEV® in Republic of Korea

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

Safety Surveillance After Immunization With IXIARO

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51